Growing demand for reliable early-stage diagnosis of chronic ailments is likely to add impetus to molecular diagnostics market growth over the forecast spell.
Growing demand for reliable early-stage diagnosis of chronic ailments is likely to add impetus to molecular diagnostics market growth over the forecast spell. This growth is largely characterized by prolific technological advancements and the subsequent development of sophisticated molecular diagnosis techniques.
Molecular diagnostic techniques are a collection of solutions used for the analysis of biological markers across a vast array of ailments. These techniques offer myriad benefits to clinical and medical settings, delivering sensitive and rapid detection & monitoring approaches for contagious diseases, chronic ailments, and cancer, among others.
Furthermore, there has been a significant upsurge in R&D efforts and research studies across the world in recent years, which has contributed significantly to industry expansion. Innovative technological solutions such as mass spectroscopy, in-situ Hybridization, and PCR are integral parts of these research studies.
In addition to rising research and development efforts, the rising prevalence of infectious disease worldwide, alongside rising demand for point-of-care diagnostic solutions are some more factors that will add further impetus to molecular diagnostics industry demand over the years ahead.
Based on estimates from a Global Market Insights, Inc. report, global molecular diagnostics market size is anticipated to cross $15 billion by 2026.
Prolific advancements in molecular diagnostics solutions
Global molecular diagnostics market outlook has witnessed several advancements over the years, owing to robust efforts from industry players to develop innovative products and achieve commendable market share. Research studies pertaining to molecular diagnostics solutions have offered a deep insight of molecular attributes to the healthcare industry, to facilitate a better understanding of human health and develop care standards for diagnosis of diseases.
To illustrate, the introduction of NAAT (nucleic acid amplification test) devices has given healthcare professionals access to more advanced diagnostic tools. Since these tools possess high specificity, sensitivity and offer superior quality results, the CDC or Centers for Disease Control and Prevention has certified NAAT as the gold standard for the diagnosis and detection of various ailments such as influenza, malaria, and trichomonas. This in turn is likely to present lucrative growth prospects for the global market outlook in the forthcoming years.
To access sample pages of this report titled, “Molecular Diagnostics Market Size By Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), By Technology (PCR, In Situ Hybridization, Chips And Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026” in detail along with the table of contents, please click on the link below:
https://www.gminsights.com/request-sample/detail/434
Higher use of sequencing devices for reliable disease diagnosis
With regards to technology, the molecular diagnostics industry is categorized into in-situ hybridization, mass spectrometry, PCR, sequencing, isothermal amplification, and chips & microarrays. Of these, the sequencing segment is anticipated to exhibit a significant growth rate of over 12% CAGR through 2026.
Novel assays derived from advanced sequencing solutions are being created to enable healthcare professionals to tap into higher genomic power. Many devices based on sequencing can offer reliable and accurate diagnostic testing and screening, which helps healthcare workers achieve the speed and accuracy required to improve human understanding of ailments and disorders and in turn reduce detection and turnaround time.
Burgeoning demand for robust diagnostic solutions from Germany
Germany molecular diagnostics market is poised to depict substantial growth at a rate of over 7.5% CAGR through 2026, owing to rising demand for early diagnosis through efficient diagnostic procedures.
Furthermore, evolving lifestyle preferences, alongside rising prevalence of contagious diseases and propitious demographic trends such as a rising aged population are likely to boost molecular diagnostics industry dynamics in the region.
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com